BridgeMD
New treatment option for Mild Cognitive Impairment
Official title Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia
ClinicalTrials.gov ID: NCT07234357
What this study is testing
- What it's testing
- To determine if diffusion aromatherapy exposure to an essential oil blend can potentially improve mild cognitive impairment/mild dementia symptoms and relieve caregiver stress. This study also allows us to gauge the willingness of elderly patients in complying with long-term aromatherapy treatments.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 99
You may be able to join if
- For patients:
- Aged 50 years old and above.
- Confirmed diagnosis of MCI or mild dementia based on clinical records.
- Has one identified caregiver aged 21 years and above who is willing to provide written informed consent for his/her own participation; is able to...
- Aged 21 years old and above.
You likely can't join if
- For patients:
- Olfactory impaired/dysfunctional.
- Known or suspected hypersensitivity/allergy to essential oils or any components of the formulations.
- Has Reactive Airway Disease (e.g, Asthma).
- Participant without a caregiver.
- Pregnant, breastfeeding, or intending to conceive during study period. For caregivers:
See the full eligibility criteria
- For patients:
- Aged 50 years old and above.
- Confirmed diagnosis of MCI or mild dementia based on clinical records.
- Has one identified caregiver aged 21 years and above who is willing to provide written informed consent for his/her own participation; is able to read, understand, and speak the designated language at the study site...
- Aged 21 years old and above.
- Willing and able to provide written informed consent
- Identified as the caregiver for recruited patient in this study can read, understand, and speak the designated language at the study site; either lives with the recruited patients or sees the patient for ≥2 hours/day ≥3...
- Agrees to accompany the patient to each study visit; and can verify daily compliance with study intervention.
- For patients:
- Olfactory impaired/dysfunctional.
- Known or suspected hypersensitivity/allergy to essential oils or any components of the formulations.
- Has Reactive Airway Disease (e.g, Asthma).
- Participant without a caregiver.
- Pregnant, breastfeeding, or intending to conceive during study period. For caregivers:
- Physically or mentally incapable of providing verbal / written consent
- Does not have regular or meaningful contact with the participant (e.g. less than 2 hours/day or less than 3 days/week).
- Not able to follow patient to each study visit.
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.